CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,527,058 | -13.2% | 231,925 | +7.4% | 0.28% | -10.4% |
| Q2 2023 | $12,124,758 | +61.7% | 215,974 | +30.3% | 0.31% | +53.2% |
| Q1 2023 | $7,498,268 | +42.0% | 165,781 | +27.6% | 0.20% | +34.0% |
| Q4 2022 | $5,281,008 | -23.9% | 129,914 | +1.2% | 0.15% | -30.2% |
| Q3 2022 | $6,941,000 | -9.3% | 128,362 | +2.0% | 0.22% | -6.1% |
| Q2 2022 | $7,650,000 | +16.1% | 125,885 | +19.9% | 0.23% | +26.5% |
| Q1 2022 | $6,590,000 | -15.1% | 104,982 | +2.4% | 0.18% | -13.0% |
| Q4 2021 | $7,765,000 | -1.8% | 102,472 | +45.0% | 0.21% | -11.5% |
| Q3 2021 | $7,910,000 | -29.7% | 70,672 | +1.7% | 0.24% | -30.3% |
| Q2 2021 | $11,248,000 | +36.2% | 69,481 | +2.5% | 0.34% | +24.8% |
| Q1 2021 | $8,256,000 | -38.5% | 67,757 | -22.7% | 0.27% | -43.6% |
| Q4 2020 | $13,423,000 | +17.2% | 87,668 | -36.0% | 0.48% | +3.2% |
| Q3 2020 | $11,450,000 | -9.7% | 136,900 | +0.3% | 0.46% | -12.1% |
| Q2 2020 | $12,686,000 | +123.9% | 136,497 | +2.2% | 0.53% | +72.0% |
| Q1 2020 | $5,665,000 | -26.8% | 133,579 | +5.2% | 0.31% | -8.4% |
| Q4 2019 | $7,737,000 | +41.4% | 127,029 | +9.4% | 0.34% | +23.6% |
| Q3 2019 | $5,471,000 | 0.0% | 116,157 | 0.0% | 0.27% | 0.0% |
| Q2 2019 | $5,471,000 | +191.8% | 116,157 | +121.3% | 0.27% | +34.8% |
| Q1 2019 | $1,875,000 | -44.3% | 52,479 | -55.5% | 0.20% | -8.2% |
| Q4 2018 | $3,366,000 | -29.4% | 117,819 | +9.7% | 0.22% | -22.9% |
| Q3 2018 | $4,765,000 | -23.8% | 107,432 | +0.9% | 0.28% | -24.5% |
| Q2 2018 | $6,254,000 | -8.1% | 106,441 | -28.5% | 0.38% | -7.8% |
| Q1 2018 | $6,807,000 | +93.7% | 148,917 | -0.5% | 0.41% | +98.1% |
| Q4 2017 | $3,515,000 | – | 149,704 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |